LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology
Go back to LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology| Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) | Delayed: 7.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.30 | 52 Week High | $1.50 | |||
| Open | $7.30 | 52 Week Low | $0.08 | |||
| Day High | $7.30 | P/E | N/A | |||
| Day Low | $7.30 | EPS | $-0.05 | |||
| Volume | 61 | |||||
